Core Scientific (NASDAQ:CORZ) Given “Overweight” Rating at Cantor Fitzgerald

Core Scientific (NASDAQ:CORZ)‘s stock had its “overweight” rating restated by equities researchers at Cantor Fitzgerald in a report issued on Wednesday, Benzinga reports. They presently have a $39.00 price target on the stock. Cantor Fitzgerald’s target price would indicate a potential upside of 175.35% from the stock’s current price.

Several other equities research analysts also recently commented on CORZ. Weiss Ratings reiterated a “sell (d-)” rating on shares of Core Scientific in a report on Friday, July 17th. Canaccord Genuity Group boosted their target price on Core Scientific from $30.00 to $36.00 and gave the stock a “buy” rating in a research report on Wednesday, July 29th. Keefe, Bruyette & Woods raised Core Scientific from a “market perform” rating to an “outperform” rating and boosted their target price for the stock from $25.00 to $28.00 in a research report on Thursday, July 30th. BTIG Research reissued a “buy” rating and issued a $38.00 target price on shares of Core Scientific in a research report on Tuesday, July 28th. Finally, B. Riley Financial boosted their target price on Core Scientific from $33.00 to $42.00 and gave the stock a “buy” rating in a research report on Monday, August 3rd. Two equities research analysts have rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Core Scientific has a consensus rating of “Moderate Buy” and an average price target of $31.36.

Core Scientific Stock Performance

Shares of CORZ traded up $0.65 on Wednesday, hitting $14.16. 26,403,278 shares of the stock traded hands, compared to its average volume of 12,647,161. The company has a market capitalization of $4.55 billion, a PE ratio of -3.21 and a beta of 5.49. The business has a 50 day simple moving average of $17.58 and a 200 day simple moving average of $21.05. Core Scientific has a one year low of $12.31 and a one year high of $30.46.

Core Scientific (NASDAQ:CORZ) last announced its quarterly earnings results on Tuesday, July 28th. The company reported ($3.32) earnings per share for the quarter, missing the consensus estimate of ($0.06) by ($3.26). The company had revenue of $164.20 million for the quarter, compared to the consensus estimate of $144.83 million. On average, equities analysts expect that Core Scientific will post -1.36 earnings per share for the current year.

Insiders Place Their Bets

In other Core Scientific news, insider Todd DuChene sold 10,000 shares of the business’s stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $19.97, for a total value of $199,700.00. Following the completion of the transaction, the insider owned 1,969,101 shares of the company’s stock, valued at approximately $39,322,946.97. The trade was a 0.51% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Over the last ninety days, insiders bought 19,000 shares of company stock valued at $342,290 and sold 100,000 shares valued at $1,881,300. Company insiders own 1.70% of the company’s stock.

Institutional Investors Weigh In On Core Scientific

A number of large investors have recently made changes to their positions in the company. BlackRock Inc. bought a new stake in shares of Core Scientific during the 2nd quarter valued at about $719,649,000. Jericho Capital Asset Management L.P. grew its stake in shares of Core Scientific by 11.4% during the 4th quarter. Jericho Capital Asset Management L.P. now owns 13,038,619 shares of the company’s stock valued at $189,842,000 after purchasing an additional 1,338,796 shares during the period. Bank of America Corp DE grew its stake in shares of Core Scientific by 412.5% during the 1st quarter. Bank of America Corp DE now owns 4,806,363 shares of the company’s stock valued at $71,903,000 after purchasing an additional 3,868,535 shares during the period. Clearline Capital LP grew its stake in shares of Core Scientific by 274.2% during the 4th quarter. Clearline Capital LP now owns 4,689,443 shares of the company’s stock valued at $68,278,000 after purchasing an additional 3,436,127 shares during the period. Finally, Apollo Management Holdings L.P. bought a new stake in shares of Core Scientific during the 2nd quarter valued at about $115,671,000.

Trending Headlines about Core Scientific

Here are the key news stories impacting Core Scientific this week:

• Positive Sentiment: Analysts continue to express strong confidence in Core Scientific’s artificial-intelligence and high-density data-center strategy. Canaccord Genuity reaffirmed a “buy” rating with a $36 price target, while BTIG Research maintained its “buy” rating with a $38 target. Cantor Fitzgerald also reiterated its “overweight” rating and $39 target. These targets imply substantial upside from recent trading levels and may provide support for the shares. Canaccord Genuity reiterates buy rating on Core Scientific
• Positive Sentiment: Needham has reiterated a $35 price target, and the broader analyst consensus remains favorable, with a “Moderate Buy” rating and an average target near $31.36. The optimistic targets reflect expectations that Core Scientific can expand beyond cryptocurrency mining into AI and high-performance-computing infrastructure.
• Neutral Sentiment: Core Scientific will release its third-quarter 2026 results before the market opens on November 5, followed by a conference call. The report will be an important near-term catalyst because investors will look for updates on data-center capacity, customer commitments, revenue growth and profitability. Core Scientific schedules third-quarter 2026 earnings release
• Negative Sentiment: Insider Todd DuChene sold 10,000 shares for approximately $151,200, reducing his position by 0.85%. Although he retains a large stake, the sale may create a modest negative signal for investors. Core Scientific insider sells $151,200 in stock
• Negative Sentiment: Needham’s target reiteration came as tenant CoreWeave faces credit pressure. Any deterioration in CoreWeave’s financial condition could raise concerns about customer concentration, contract execution or future expansion, partially offsetting the bullish analyst forecasts. Needham reiterates Core Scientific price target amid CoreWeave credit pressure

Core Scientific Company Profile

Core Scientific, Inc is a digital infrastructure company that develops and operates data centers in the United States. Its business has historically centered on cryptocurrency mining, particularly the processing of transactions on the Bitcoin network, while also providing hosting and infrastructure services to other mining and technology customers.

The company is expanding its data center capabilities to support high-performance computing and artificial intelligence workloads. Its services include data center operations, power and equipment management, hosting, and related infrastructure support for customers that require substantial computing capacity.

Core Scientific was founded in 2017 and became a publicly traded company through a business combination in 2022.